Quercetin ameliorate insulin resistance and up-regulates cellular antioxidants during oleic acid induced hepatic steatosis in HepG2 cells

Toxicology in Vitro

Volumn 27, Issue 2, 2013, Pages 945-953

  Vidyashankar, Satyakumar ^a   Sandeep Varma, R ^a   Patki, Pralhad Sadashiv ^a  

^a Himalaya Health Care   (India)

Author keywords

Glutathione; HepG2 cells; Insulin resistance; Non alcoholic fatty liver disease; Oleic acid; Quercetin; TNF alpha

Indexed keywords

ALBUMIN; ALPHA TOCOPHEROL; CATALASE; FAT DROPLET; GLUCOSE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; INSULIN; INTERLEUKIN 8; LIPID PEROXIDE; OLEIC ACID; QUERCETIN; SILYMARIN; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UREA;

ANTIOXIDANT ACTIVITY; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVITY; FATTY LIVER; GENE EXPRESSION; GLUCOSE TRANSPORT; INSULIN RESISTANCE; LIPID PEROXIDATION; UPREGULATION;

ALANINE TRANSAMINASE; ALBUMINS; ANTIOXIDANTS; CYTOKINES; DNA FRAGMENTATION; FATTY LIVER; GLUCOSE; GLUTATHIONE; HEP G2 CELLS; HUMANS; INSULIN RESISTANCE; LIPID PEROXIDATION; OLEIC ACID; QUERCETIN; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION; UREA;

EID: 84873696060     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2013.01.014     Document Type: Article

References (55)

1. Abdul-Ghani M.A., Muller F.L., Liu Y. Deleterious action of FA metabolites on ATP synthesis: possible link between lipotoxicity, mitochondrial dysfunction, and insulin resistance. American Journal of Physiology Endocrinology Metabolism 2008, 295:E678-E685.
2. Adachi M., Ishii H. Role of mitochondria in alcoholic liver injury. Free Radical Biology and Medicine 2002, 32:487-491.
3. Aebi H. Catalase in vitro. Methods in Enzymology 1984, 105:121-126.
4. Amalia P.M., Possa M.N., Augusto M.C., Francisca L.S. Quercetin prevents oxidative stress in cirrhotic rats. Digestive Diseases and Sciences 2007, 52:2616-2621.
5. Anderson M.E. Determination of glutathione and glutathione disulfide in biological samples. Methods in Enzymology 1985, 113:548-555.
6. Arts I.C., Hollman P.C. Polyphenols and disease risk in epidemiologic studies. American Journal of Clinical Nutrition 2005, 81:317S-325S.
7. Barve S.J., Barve S.S., Amancherla K., Gobejishvili L., Hill D., Cave M., Hote P., McClain C.J. Palmitic acid induces production of proinflammatory cytokine interleukin-8 from hepatocytes. Hepatology 2007, 46:823-830.
8. Belfort R., Mandarino L., Kashyap S., Wirfel K., Pratipanawatr T., Berria R., DeFronzo R.A., Cusi K. Dose-response effect of elevated plasma free fatty acid on insulin signalling. Diabetes 2005, 54:1640-1648.
9. Bellomo G., Jewell S.A., Thor H., Orrenius S. Regulation of intracellular calcium compartmentation: studies with isolated hepatocytes and t-butylhydroperoxide. Proceedings of National Academy of Sciences 1982, 79:6842-6846.
10. Boots A.W., Li H., Schins R.P.F. The quercetin paradox. Toxicology and Applied Pharmacology 2007, 222:89-96.
11. Borel P., Moussa M., Reboul E., Lyan B., Defoort C., Vincent-Baudry S., Maillot M., Gastaldi M., Darmon M., Portugal H., Planells R., Lairon D. Human plasma levels of vitamin E and carotenoids are associated with genetic polymorphisms in genes involved in lipid metabolism. Journal of Nutrition 2007, 137:2653-2659.
12. Browning J.D., Horton J.D. Molecular mediators of hepatic steatosis and liver injury. The Journal of Clinical Investigation 2004, 114(2):147-152.
13. Buc-Calderon P., Latour I., Roberfroid M. Biochemical changes in isolated hepatocytes exposed to tert-butyl hydroperoxide. Implications for its cytotoxicity. Cell Biology and Toxicology 1991, 7:129-143.
14. Cai S., Huang C., Ji B., Zhou F., Wise M.L., Zhang D., Yang P. In vitro antioxidant acitivity and inhibitory effect, on oleic acid-induced hepatic steatosis, of fractions and subfractions from oat (Avena sativa L.) ethanol extract. Food Chemistry 2011, 124:900-905.
15. Castell J.V., Gomez-Lechon M.J., Ponsoda X., Bort R. In vitro investigation of the molecular mechanisms of hepatotoxicity. In vitro Methods in Pharmaceutical Research 1997, 375-410. Academic Press, London. J.V. Castell, M.J. Gomez-Lechon (Eds.).
16. Cui W., Chen S.L., Hu K.Q. Quantification and mechanisms of oleic acid-induced steatosis in HepG2 cells. American Journal of Translational Research 2010, 2(1):95-104.
17. Day C.P., James O.F.W. Steatohepatitis: a tale of two 'hits'?. Gastroenterology 1998, 114:842-845.
18. Falck-Yerrer Y., Younossi Z.M., Marchesini G., McCullough A.J. Clinical features and natural history of non-alcoholic steatosis syndromes. Seminars in Liver Disease 2001, 21:17-26.
19. Feldstein A.E., Werenburg N.W., Canbay A. Free fatty acids promote hepatic lipotoxicity by stimulating TNF-α expression via lysosomal pathway. Hepatology 2004, 40:185-194.
20. Flohe L., Gunzler W.A. Assays of glutathione peroxidase. Methods in Enzymology 1984, 105:114-121.
21. Flohe L., Otting O. Superoxide dismutase assays. Methods in Enzymology 1984, 105:93-104.
22. Hoffman D.L., Boookes P.S. Oxygen sensitivity of mitochondrial reactive oxygen species generation depends on metabolic conditions. Journal of Biological Chemistry 2009, 284:16236-16245.
23. Inoue M. Protective mechanisms against reactive oxygen species. The Liver: Biology and Pathobiology 1994, 443-459. Raven, New York. I.M. Arias, N. Fausto, W.B. Jakoby, D. Schachter, D.A. Shafritz (Eds.).
24. Jewell S.A., Di Monte D., Richelmi P., Bellomo G., Orrenius S. Tert-butylhydroperoxide-induced toxicity in isolated hepatocytes: contribution of thiol oxidation and lipid peroxidation. Journal of Biochemical Toxicology 1986, 1:13-22.
25. Kedderis G.L. Biochemical basis of hepatocellular injury. Toxicologic Pathology 1996, 24:77-83.
26. Knobler H., Schattner A., Zhornicki T., Malnick S.D.H., Keter D., Sokolovskaya N., Lurie Y. Fatty liver - an additional and treatable feature of the insulin resistance syndrome. Quarterly Journal of Medicine 1999, 92:73-79.
27. Kobori M., Masumoto S., Akimoto Y., Oike H. Chronic dietary intake of quercetin alleviates hepatic fat accumulation associated with consumption of a Westerrn-style diet in C57/BL6J mice. Molecular Nutrition and Food Research 2011, 55:530-540.
28. Kugelmas M., Hill D.B., Vivian B., Marsano L., McClain C.J. Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E. Hepatology 2003, 38:413-419.
29. Lander H.M. An essential role for free radicals and derived species in signal transduction. The Journal of the Federation of American Societies for Experimental Biology 1997, 11:118-124.
30. Ludwig J., Viggiano T.R., McGill D.B., Oh B.J. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disase. Mayo Clinic Proceedings 1980, 55:434-438.
31. Luyckx F.X., Lefebvre P.J., Scheen A.J. Nonalcoholic steatohepatitis: association with obesity and insulin resistance and influence of weight loss. Diabetes and Metabolism 2000, 26:98-106.
32. Marcolin E., San Miquel B., Vallejo D., Tieppo J., Marroni N., Gonzales-Gallego J., Tunon M.J. Quercetin treatment ameliorates inflammation and fibrosis in mice with non alcoholic steatohepatitis. Journal of Nutrition 2012, 142:1821-1828.
33. Martin C., Martinez R., Navarro R., Ruiz-Sanz J.I., Lacort M., Ruiz-Larrea M.B. Tert-butyl hydroperoxide-induced lipid signaling in hepatocytes: involvement of glutathione and free radicals. Biochemical Pharmacology 2001, 62:705-712.
34. Mersch-Sundermannn V., Knasmullar S., Wu X.J., Darroudi F., Kassie F. Use of a human-derived liver cell line for the detection of cytoprotective, antigenotoxic and cogenotoxic agents. Toxicology 2004, 198:329-340.
35. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of Immunological Methods 1983, 65:55-63.
36. 2+ concentration and cytotoxicity in hepatocytes exposed to oxidative stress. Toxicology 1988, 52:55-63.
37. Ohkawa H., Ohishi U., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric reaction. Analytical Biochemistry 1979, 95:145-149.
38. Park H.J., DiNatale D.A., Chung M.Y., Park Y.K., Lee J.Y., Koo S.I., Connor M., Manautou J.E., Bruno R.S. Green tea extracts attenuates hepatic steatosis by decreasing adipose lipogenesis and enhancing hepatic antioxidants defences in ob/ob mice. Journal of Nutritional Biochemistry 2011, 22:393-400.
39. Perandones C.E., Illera V.A., Peckham D., Stunz L.L., Ashman R.F. Regulation of apoptosis in vitro in mature murine spleen T cell. Journal of Immunology 1993, 151:3521-3529.
40. Peres W., Tunon J.M., Collado P.S., Herrmann S., Marron N., Gonazalez-Gallego J. The flavanoid quercetin ameliorates liver damage in rats with biliary obstruction. Journal of Hepatology 2000, 33:742-750.
41. Radtke J., Linseisen J., Wolfram G. Fasting plasma concentrations of selected flavonoids as markers of their ordinary dietary intake. European Journal of Nutrition 2002, 41:203-209.
42. Rasband, W.S. 1997-2004. ImageJ, National Institutes of Health, Bethesda, Maryland, USA. <>. http://rsb.info.nih.gov/ij/.
43. Robertson G., Leclercq L., Farrell G.C. Nonalcoholic steatosis and steatohepatitis II. Cytochrome P-450 enzymes and oxidative stress. American Journal of Physiology-Gastrointestinal and Liver Physiology 2001, 281(5445):G1135-G1139.
44. Sanyal A.J., Chalasani N., Kowdley K.V., McCullough A., et al. Pioglitazone, vitamin E or placebo for non-alcoholic steatohepatitis. The New England Journal of Medicine 2010, 362:1675-1685.
45. Scalbert A., Manach C., Morand C., Remesy C., Jimenez L. Dietary polyphenols and the prevention of diseases. Critical Reviews of Food Science and Nutrition 2005, 45:287-306.
46. Sies H. Oxidative stress: introductory remarks. Oxidative Stress 1985, 1-9. Academic Press, London. H. Sies (Ed.).
47. Song Z., Song M., Lee D.Y.W., Liu Y., Deaciue I.V., McClain C.J. Silymarin prevents palmitate-induced lipotoxicity in HepG2 cells: involvement of maintenance of Akt kinase activation. Basic and Clinical Pharmacology and Toxicology 2007, 101:262-268.
48. Sorbi D., Boynton J., Lindor K.D. The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating non-alcoholic steatohepatitis from alcoholic liver disease. The American Journal of Gastroenterology 1999, 94:1018-1022.
49. Tieppo J., Cuevas M.J., Vercelino R. Quercetin administration ameliorates pulmonary complications of cirrhosis in rats. Journal of Nutrition 2009, 139:1339-1346.
50. Tilg H., Diehl A.M. Cytokines in alcoholic and non-alcoholic steatohepatitis. New England Journal of Medicine 2000, 343:1467-1476.
51. Valenti L., Fracanzani A.L., Dongiovanni P., Santorelli G., Branchi A., Taioli E., Fiorelli G. Tumor necrosis factor alpha promoter polymorphisms and insulin resistance in non-alcoholic fatty liver disease. Gastroenterology 2002, 122:274-280.
52. Vidyashankar S., Mitra S.K., Nandakumar K.S. Liv.52 protects HepG2 cells from oxidative damage induced by tert-butyl hydroperoxide. Molecular and Cellular Biochemistry 2010, 333:41-48.
53. Vidyashankar S., Patki P.S. Liv.52 attenuate copper induced toxicity by inhibiting glutathione depletion and increased antioxidant enzyme activity in HepG2 cells. Food and Chemical Toxicology 2010, 48:1863-1868.
54. Wigg A.J., Roberts-Thomson I.C., Dymock R.B., McCarthy P.J., Crose R.H., Cummins A.G. The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumor necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis. Gut 2001, 48:148-149.
55. Yonemitsu S., Nishimura H., Shintani M., Inoue R., Yamamoto Y., Masuzaki H., Ogawa Y., Hosoda K., Inoue G., Hayashi T., Nakao Kazuwa Troglitazone induces GLUT4 translocation in L6 mytotubes. Diabetes 2001, 50:1093-1101.